궤양성 대장염 유발 생쥐에서 두시추출물의 항염증 효과

키워드

참고문헌 (42)

1. Xavier RJ, "Unravelling the pathogenesis of inflammatory bowel disease", Nature, 448(7152), pp.427~434 (2007)
2. Lee JH, "Inflammatory bowel disease in pediatric age", Korean J Pediatr Gastroenterol Nutr, 14(1), pp.34~41 (2011)
3. Song I, "Inflammatory bowel disease in Korean", Korean Journal of Medicine, 57(4), pp.661~675 (1999)
4. Kwak MS, "Emerging trends of inflammatory bowel disease in south korea : a nationwide population-based study", J Gastroenterol Hepatol, 34(6), pp.1018~1026 (2019)
5. Jess T, "Risk of intestinal cancer in inflammatory bowel disease : a population-based study from Olmsted County, Minnesota", Gastroenterology, 130(4), pp.1039~1046 (2006)
6. 김덕환, "Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies", Immune Network, 17(1), pp.25~40 (2017), 대한면역학회[DOI]
7. Guo BJ, "Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease", Ann N Y Acad Sci, 1401(1), pp.37~48 (2017)
8. SHI Y, "Exacerbation of bloody diarrhea as a side effect of mesalamine treatment of active ulcerative colitis", Case Rep Gastroenterol, 5(1), pp.159~165 (2011)
9. 박정은, "크론병 환자에서 메살라진 투여 중 발생한 호산구 폐렴 1예", 대한소화기학회지, 53(2), pp.116~120 (2009), 대한소화기학회
10. Foster RA, "Mesalamine related lung disease : clinical, radiographic, and pathologic manifestations", Inflamm Bowel Dis, 9(5), pp.308~315 (2003)
11. Abraham A, "Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis", BMJ Case Rep, 2013, pp.bcr2013009~ (2013)
12. Shah N, "Mesalamine:good for IBD but bad for the liver? A case of DILI caused by mesalamine", American J gastroenterol, 113, pp.1267~1268 (2018)
13. 안상현, "두시 하태독법이 시행된 비만 생쥐에서 Th2 분화조절을 통한 알러지성 비염 유발 감소 효과", 대한한방소아과학회지, 32(2), pp.1~10 (2018), 대한한방소아과학회[DOI]
14. 안상현, "PKC 활성 조절을 통한 두시 하태독법의 항염증작용이 Mite 항원 유도 아토피유사피부염 발병 조절에 미치는 효과", 대한한방소아과학회지, 30(4), pp.77~86 (2016), 대한한방소아과학회
15. Jung AR, "Douchi (fermented Glycine max Merr.)alle- viates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
16. Zhang JH, "Angiotensin I-converting enzyme inhibitory peptides in Douchi, a Chinese traditional fermented soybean product", Food Chem, 98(3), pp.551~557 (2006)
17. Lin J, "Genistein suppresses smooth muscle cell-derived foam cell formation through tyrosine kinase pathway", Biochem Biophys Res Commun, 463(4), pp.1297~1304 (2015)
18. Bao ZS, "Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma", Int Immunopharmacol, 11(8), pp.899~906 (2011)
19. 안상현, "Th2 skewed condition 조절을 통한 대장점막 내 염증개선효과에 대한 두시 하태독법과 오메가3 비교 연구", 대한한방소아과학회지, 31(3), pp.37~45 (2017), 대한한방소아과학회
20. 안상현, "3주된 생쥐에서 궤양성 대장염 유발을 통한 폐-대장-피부의 상관관계 연구", 대한한방소아과학회지, 33(3), pp.103~111 (2019), 대한한방소아과학회[DOI]
21. 한동수, "다량의 복수가 주 증상으로 나타난 POEMS 증후군 1예", 대한소화기학회지, 40(3), pp.1~1 (2002), 대한소화기학회
22. Talbot RW, "Vascular complications of inflammatory bowel disease", Mayo Clin Proc, 61(2), pp.140~145 (1986)
23. 김준성, "궤양성 대장염에 동반된 간정맥 혈전증 1예", Pediatric Gastroenterology, Hepatology & Nutrition, 12(2), pp.235~239 (2009), 대한소아소화기영양학회
24. Fiocchi C, "Inflammatory bowel disease : new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy", Curr Opin Gastroenterol, 20(4), pp.309~310 (2004)
25. 이광재, "염증성 장질환의 약물요법", 대한의사협회지, 58(1), pp.57~63 (2015), 대한의사협회[DOI]
26. Kornbluth A, "Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 105(3), pp.501~523 (2010)
27. 강아미, "궤양성 대장염 유발 생쥐에 투여한 계지가용골모려탕의 치료효과", 대한한방내과학회지, 38(6), pp.1021~1034 (2017), 대한한방내과학회
28. 허경, "薏苡仁 추출물이 DSS(dextran sulfate sodium)로 유발된 생쥐의 궤양성 대장염에 미치는 영향", 대한한방내과학회지, 33(4), pp.520~532 (2012), 대한한방내과학회
29. 정호경, "식방풍 잎의 DSS로 유도한 궤양성 대장염 완화 효과", 한국자원식물학회지, 27(5), pp.421~428 (2014), 한국자원식물학회[DOI]
30. Baeuerle PA, "IκB-NF-κB structure : at the interface of inflammation control", Cell, 95(6), pp.729~731 (1998)
31. Liu T, "NF-κB signaling in inflammation", Signal Transduct Target Ther, 2, pp.17023~ (2017)
32. Bogdan C, "Nictric oxide and the immune response", Nat immunol, 2(10), pp.907~916 (2001)
33. Watanabe K, "Nuclear-factor kappa B(NF-KB)-inducible nitric oxide synthase(iNOS", NOS II)pathway damages the stria Vascularis in cisplatin-treated mice, 2002, pp.22(6), 4081~4085
34. Park YS, "COX-2 inhibitors in inflammatory bowel disease : friends or foes?", Korean J Gastroenterol, 50(6), pp.350~355 (2007)
35. 황준연, "두경부 편평세포암에서 COX-2, MMP-9, p53 및 VEGF 동시발현성에 대한 면역조직화학적 연구", 대한이비인후-두경부외과학회지, 51(11), pp.1036~1042 (2008), 대한이비인후과학회
36. Edward B, "Epidermal growth factor(EGF)and somatomedin C regulate G1 progression in competent BALB", c-3T3cells, 1982, pp.141(1), 107~115
37. Watt BE, "Hydrogen peroxide poisoning", Toxicological Reviews, 23(1), pp.51~57 (2004)
38. Nao O, "The role of catalase in pulmonary fibrosis", Respiratory Research, 11, pp.183~195 (2010)
39. Isabel M, "Impact ofthe Loss of Hoxa5 Function on Lung Alveogenesis", American J Pathology, 169(4), pp.1312~1327 (2006)
40. Olivier B, "Partial functional redundancy between Hoxa5 and Hoxb5 paralog genes during lung morphogenesis", Am J Physiol Lung Cell Mol Physiol, 304(12), pp.817~830 (2013)
41. Saki S, "A novel long non-coding rna from the hoxa6-hoxa5locus facilitates colon cancer cell growth", BMC Cancer, 19(1), pp.1~14 (2019)
42. Vamsee DM, "Mesenchymal stromal cells from infants with simple polydactyly mo dulate immune responses more efficiently than adult mesenchymal stromal cells", Cytptheraphy, 21(2), pp.148~161 (2019)

관련 논문AI추천